Literature DB >> 17166959

Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid.

Chadi A Hage, John M Reynolds, Michelle Durkin, L Joseph Wheat, Kenneth S Knox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17166959      PMCID： PMC1829015          DOI： 10.1128/JCM.01940-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.

Authors:  Olivier Adam; Anne Aupérin; Fanny Wilquin; Jean-Henri Bourhis; Bertrand Gachot; Elisabeth Chachaty
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079

2.  Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay.

Authors:  Chadi A Hage; Thomas E Davis; Lindsey Egan; Michelle Parker; Deanna Fuller; Ann M Lemonte; Michelle Durkin; Patricia Connelly; L Joseph Wheat; Deborah Blue-Hnidy; Kenneth S Knox
Journal:  Respir Med       Date:  2006-06-06       Impact factor: 3.415

3.  Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

Authors:  Alban Aubry; Raphael Porcher; Julie Bottero; Sophie Touratier; Thierry Leblanc; Benoît Brethon; Philippe Rousselot; Emmanuel Raffoux; Jean Menotti; Francis Derouin; Patricia Ribaud; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

4.  False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.

Authors:  Daniele Mattei; Davide Rapezzi; Nicola Mordini; Federica Cuda; Cristiana Lo Nigro; Maura Musso; Aldo Arnelli; Sebastiano Cagnassi; Andrea Gallamini
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.

Authors:  Benjamin Musher; David Fredricks; Wendy Leisenring; S Arunmozhi Balajee; Caitlin Smith; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

7.  Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.

Authors:  Thomas J Walsh; Shmuel Shoham; Ruta Petraitiene; Tin Sein; Robert Schaufele; Amy Kelaher; Heidi Murray; Christine Mya-San; John Bacher; Vidmantas Petraitis
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 9.  Rapid diagnosis of invasive aspergillosis by antigen detection.

Authors:  L J Wheat
Journal:  Transpl Infect Dis       Date:  2003-12       Impact factor: 2.228
  9 in total
  28 in total

Review 1.  Fungal diagnostics in pneumonia.

Authors:  Erika D Lease; Barbara D Alexander
Journal:  Semin Respir Crit Care Med       Date:  2011-12-13       Impact factor: 3.119

2.  Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.

Authors:  Jorien D'Haese; Koen Theunissen; Edith Vermeulen; Hélène Schoemans; Greet De Vlieger; Liesbet Lammertijn; Philippe Meersseman; Wouter Meersseman; Katrien Lagrou; Johan Maertens
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

3.  Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum.

Authors:  Zdenek Racil; Iva Kocmanova; Martina Lengerova; Jana Winterova; Jiri Mayer
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

4.  Contamination by cardboard particles as a cause of false-positive results for Aspergillus galactomannan enzyme immunoassays.

Authors:  Corrado Girmenia; Daniele Ballarò; Pietro Martino
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

5.  Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity.

Authors:  Ignace Surmont; Willem Stockman
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

6.  Clinical utility and development of biomarkers in invasive aspergillosis.

Authors:  Thomas F Patterson
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

7.  Nonculture diagnostic methods for invasive fungal infections.

Authors:  L Joseph Wheat
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

Review 8.  Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.

Authors:  Mary Mansour Riwes; John R Wingard
Journal:  Expert Rev Hematol       Date:  2012-12       Impact factor: 2.929

9.  Galactomannan Assay and Invasive Pulmonary Aspergillosis - Comparison of the Test Performance at an in-house and the Kit Cut-off.

Authors:  Jayanthi Savio; Nikhilesh Ravikumar Menon; Arun Ramachandran Sudharma; Vinutha Jairaj; Joshila Mathew
Journal:  J Clin Diagn Res       Date:  2016-08-01

10.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.